Current Report Filing (8-k)
March 12 2021 - 7:22AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 12, 2021
Blonder Tongue Laboratories, Inc.
(Exact
Name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
|
1-14120
(Commission
File Number)
|
52-1611421
(I.R.S.
Employer
Identification No.)
|
One Jake Brown Road, Old Bridge, New Jersey 08857
(Address
of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (732) 679-4000
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
symbol(s)
|
Name
of each exchange on which registered
|
Common
Stock, par value $.001
|
BDR
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item
2.02
|
Results
of Operations and Financial Condition.
|
On
March 12, 2021, Blonder Tongue Laboratories, Inc. issued a press release announcing its financial results for the fourth quarter
and year ended December 31, 2020. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and
is incorporated herein by reference. The information disclosed in this Current Report on Form 8-K, including Exhibit 99.1 hereto,
is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
|
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits.
The following exhibit is filed herewith:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BLONDER TONGUE LABORATORIES, INC.
|
|
|
|
By:
|
/s/ Eric Skolnik
|
|
|
Eric Skolnik
Senior Vice President and Chief Financial Officer
|
Date: March 12, 2021
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Apr 2024 to May 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From May 2023 to May 2024